Skip to content
Screener

Haemonetics HAE Total Current Assets

Total Current Assets at other companies

Abbott logo
AbbottABT
$24.52B+0.2%
TFX
TeleflexTFX
$1.88B+8.8%
Boston Scientific logo
Boston ScientificBSX
$8.68B+18.4%
Medtronic logo
MedtronicMDT
$24.79B+4.1%
LivaNova logo
LivaNovaLIVN
$1.03B-3.9%
InfuSystem Holdings logo
InfuSystem HoldingsINFU
$36.66M+3.8%

Other financials

Income statement

See full
Revenue$339.4M+5.6%
Gross profit$202.8M+5.5%
Operating income$57.5M+6.7%
Net income$33.0M-3.0%
EPS (diluted)$0.72+2.9%

Balance sheet

See full
Cash & equivalents$223.4M-23.7%
Total debt$1.2B-4.1%
Total equity$837.1M-5.1%
Total assets$2.4B-3.9%

Cash flow

See full
Operating cash flow$52.3M+201%
CapEx$7.9M+111%
Free cash flow$44.4M+226%

Valuation

See full
Market cap$3.87B+6.3%
Enterprise value$4.82B+5.4%
P/E25.7×-10.5×
P/S2.9×+0.2×

Profitability

See full
Gross margin59%+2.1pp
Operating margin19%+5.9pp
Net margin13.3%+3.8pp
FCF margin21.5%+7.5pp

Returns & leverage

See full
Return on equity19.3%+5.2pp
Debt / equity1.4×0.0×
Current ratio3.1×+1.4×

Where this comes from

Reported directly by Haemonetics in its filing.

Tagged under the XBRL concept us-gaap:AssetsCurrent.

The source filing: Haemonetics’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 6:09 AM EDT
Fiscal quarter
Q1 FY2027
Calendar quarter
Q2 2026
Accession
0000313143-26-000120
Line itemJune 27, 2026March 28, 2026
Accounts receivable, less allowance for credit losses of $3,618 as of June 27, 2026 and $3,693 as of March 28, 2026216,071216,855
Inventories, net306,739306,370
Prepaid expenses and other current assets64,63866,214
Total current assets810,832834,879
Property, plant and equipment, net303,778305,761
Intangible assets, less accumulated amortization of $374,828 as of June 27, 2026 and $363,763 as of March 28, 2026434,512447,655
Goodwill656,884656,368
Deferred tax asset9,4349,521

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Haemonetics's total current assets?
Haemonetics (HAE) reported total current assets of $810.83M in Q2 2026.
How has Haemonetics's total current assets changed year-over-year?
Haemonetics's total current assets decreased by 11.2% year-over-year, from $913.16M to $810.83M.
What is the long-term trend for Haemonetics's total current assets?
Over 5 years (2021 to 2026), Haemonetics's total current assets has grown at a 3.8% compound annual growth rate (CAGR), from $693.55M to $834.88M.
What does total current assets mean?
The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.

Ask your AI about Haemonetics's total current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude